Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation

International Journal of Cardiology

Volumn 201, Issue , 2015, Pages 513-516

  Pastori, Daniele ^a   Pignatelli, Pasquale ^a   Saliola, Mirella ^a   Carnevale, Roberto ^a   Vicario, Tommasa ^a   Del Ben, Maria ^a   Cangemi, Roberto ^a   Barillà, Francesco ^a   Lip, Gregory Y H ^b   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Anticoagulant drugs; Atrial fibrillation; Cardiovascular diseases; Myocardial infarction; Warfarin

Indexed keywords

ANTIVITAMIN K; ACENOCOUMAROL; ANTICOAGULANT AGENT; VITAMIN K GROUP; WARFARIN;

AGED; ANTICOAGULATION; ARTHROPATHY; ARTICLE; ATRIAL FIBRILLATION; BLADDER BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG FATALITY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; INTRAOCULAR HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MUSCLE BLEEDING; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; TRANSIENT ISCHEMIC ATTACK; ANTAGONISTS AND INHIBITORS; BLEEDING; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; COMPLICATION; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; STROKE; VERY ELDERLY;

ACENOCOUMAROL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MALE; MYOCARDIAL INFARCTION; PATIENT OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; STROKE; VITAMIN K; WARFARIN;

EID: 84943514263     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.08.054     Document Type: Article

References (26)

1. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
2. E.Z. Soliman, M.M. Safford, P. Muntner, Y. Khodneva, F.Z. Dawood, N.A. Zakai, and et al. Atrial fibrillation and the risk of myocardial infarction JAMA Intern. Med. 174 2014 107 114
3. F. Violi, G. Davi, W. Hiatt, G.Y. Lip, G.R. Corazza, F. Perticone, and et al. Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy J. Am. Coll. Cardiol. 62 2013 2255 2256
4. L. Polimeni, L. Perri, M. Saliola, S. Basili, and F. Violi The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue Intern. Emerg. Med. 5 2010 91 94
5. D. Pastori, P. Pignatelli, F. Angelico, A. Farcomeni, M. Del Ben, T. Vicario, and et al. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors Chest 147 2015 1644 1650
6. R. De Caterina, S. Husted, L. Wallentin, F. Andreotti, H. Arnesen, F. Bachmann, and et al. Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease Thromb. Haemost. 110 2013 1087 1107
7. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann. Intern. Med. 146 2007 857 867
8. L. Testa, G.B. Zoccai, I. Porto, G. Trotta, P. Agostoni, F. Andreotti, and et al. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes Am. J. Cardiol. 99 2007 1637 1642
9. M.B. Rothberg, C. Celestin, L.D. Fiore, E. Lawler, and J.R. Cook Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit Ann. Intern. Med. 143 2005 241 250
10. H.D. White, M. Gruber, J. Feyzi, S. Kaatz, H.F. Tse, S. Husted, and et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V Arch. Intern. Med. 167 2007 239 245
11. A. Clemens, M. Fraessdorf, and J. Friedman Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatment Vasc. Health Risk Manag. 9 2013 599 615
12. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, and E. Briet A method to determine the optimal intensity of oral anticoagulant therapy Thromb. Haemost. 69 1993 236 239
13. European Heart Rhythm A, European Association for Cardio-Thoracic S, A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, and et al. Guidelines for the management of atrial fibrillation: the task force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur. Heart J. 31 2010 2369 2429
14. G. Mancia, R. Fagard, K. Narkiewicz, J. Redan, A. Zanchetti, M. Bohm, and et al. Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension J. Hypertens. 31 2013 1925 1938
15. Authors/Task Force M, L. Ryden, P.J. Grant, S.D. Anker, C. Berne, F. Cosentino, and et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD) Eur. Heart J. 34 2013 3035 3087
16. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Bohm, K. Dickstein, and et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur. J. Heart Fail. 14 2012 803 869
17. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, H.D. White, and et al. Third universal definition of myocardial infarction J. Am. Coll. Cardiol. 60 2012 1581 1598
18. Special report from the National Institute of Neurological Disorders and Stroke Classification of cerebrovascular diseases III Stroke 21 1990 637 676
19. S. Schulman, C. Kearon, Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, and Haemostasis Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J. Thromb. Haemost. 3 2005 692 694
20. G.Y. Lip, R.G. Hart, and D.S. Conway Antithrombotic therapy for atrial fibrillation BMJ 325 2002 1022 1025
21. C.T. Ruff, R.P. Giugliano, E. Braunwald, E.B. Hoffman, N. Deenadayalu, M.D. Ezekowitz, and et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 383 2014 955 962
22. V. Roldan, F. Marin, S. Manzano-Fernandez, H. Fernandez, P. Gallego, M. Valdes, and et al. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Thromb. Haemost. 109 2013 956 960
23. R. Cangemi, P. Pignatelli, R. Carnevale, G.R. Corazza, D. Pastori, A. Farcomeni, and et al. Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation Int. J. Cardiol. 168 2013 3241 3247
24. F. Violi, and L. Loffredo Thromboembolism or atherothromboembolism in atrial fibrillation? Circ. Arrhythm. Electrophysiol. 5 2012 1053 1055
25. M.I. Aguilar, R. Hart, and L.A. Pearce Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks Cochrane Database Syst. Rev. 2007 CD006186
26. P. Colonna, M.G. Abrignani, F. Colivicchi, P. Verdecchia, G. Alunni, A.S. Bongo, and et al. ANMCO statement on prevention of thromboembolism in atrial fibrillation and role of the new oral anticoagulants G. Ital. Cardiol. 14 2013 295 322